PNUTS inhibitors, as a chemical class, predominantly consist of compounds that act on the protein phosphatase 1 (PP1) and its associated pathways, given the strong interaction between PNUTS and PP1. Notably, Okadaic Acid, Tautomycetin, and Calyculin A can directly inhibit PP1, thereby indirectly influencing PNUTS-related functions. Another unique approach is using competitors of PNUTS for PP1 binding, like NIPP1, to affect the associated processes. Additionally, compounds like Rottlerin, which can impact various kinases, can also play a role in pathways involving PNUTS.
Adenylate cyclase activation by Forskolin and phosphodiesterase inhibition by compounds such as Rolipram and Cilostazol can also potentially intersect with PNUTS functions by influencing cAMP levels. Given the diverse roles of PNUTS in cellular processes, broad spectrum modulators like TGF-β and Rapamycin, which influence multiple pathways, can impact PNUTS-involved processes. Lastly, natural compounds like Resveratrol, with their widespread cellular impacts, can indirectly modulate PNUTS functions. All these compounds, by influencing the PP1 pathway or other related pathways, can regulate the activity and roles of PNUTS in the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, including PP1, thereby indirectly influencing PNUTS-associated functions. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Another PP1 inhibitor, which can alter PNUTS-associated activity. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Although classically known as a PKCδ inhibitor, it can impact several kinases and related pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An activator of adenylate cyclase, indirectly affecting pathways where PNUTS might play a role. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Inhibits phosphodiesterase, influencing cAMP levels and potential PNUTS-involved processes. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Another phosphodiesterase inhibitor potentially impacting PNUTS-associated pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, which might be connected to cellular processes involving PNUTS. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to influence several cellular pathways that could intersect with PNUTS functions. | ||||||